CMPX Compass Therapeutics, Inc.: institutional ownership and insider trading

219 funds reported holding $408M of Compass Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net sold $24.0M, with 60 new positions and 49 funds selling out; over the last 12 months insiders bought $96.9K and sold $0 on the open market.

CMPX revenue and earnings

Famous investors holding CMPX

Largest institutional holders of CMPX

  1. VANGUARD GROUP INC — $43.2M
  2. TANG CAPITAL MANAGEMENT LLC — $39.4M
  3. ORBIMED ADVISORS LLC — $33.3M
  4. SUVRETTA CAPITAL MANAGEMENT, LLC — $30.9M
  5. BlackRock, Inc. (BLK) — $24.7M
  6. STATE STREET CORP (STT, STT-PG) — $21.8M
  7. Enavate Sciences GP, LLC — $17.1M
  8. Vivo Capital, LLC — $17.0M
  9. VANGUARD CAPITAL MANAGEMENT LLC — $13.4M
  10. Palo Alto Investors LP — $12.8M

Recent CMPX insider trades

5%+ owners

Who owns the most CMPX stock?

The largest institutional holders of Compass Therapeutics, Inc. in the latest 13F filings are VANGUARD GROUP INC ($43.2M), TANG CAPITAL MANAGEMENT LLC ($39.4M), ORBIMED ADVISORS LLC ($33.3M).

Are insiders buying or selling CMPX?

Over the last 12 months insiders bought $96.9K and sold $0 of Compass Therapeutics, Inc. stock on the open market (SEC Form 4).

Which famous investors own CMPX?

Izzy Englander, Ken Griffin, Two Sigma, D. E. Shaw.

Which ETFs hold CMPX?

2 ETFs and mutual funds hold it among their top 100 positions, including MISGX, SBIO.

All CMPX 13F holders · All CMPX insider trades